Medical Device News Magazine
HomeMARKET REPORTS

MARKET REPORTS

Traumatic Brain Injury Assessment & Management Devices Market Report 2022-2026

This 'Traumatic Brain Injury Assessment & Management Devices - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Traumatic Brain Injury Assessment & Management Devices and the historical and forecasted Traumatic Brain Injury Assessment & Management Devices market trends, globally.

New Study Cites a Possible Breakthrough Treatment In Pain Management

Pain mangement: The technique, called interventional cryoneurolysis, is performed by an interventional radiologist and can offer hope to patients in persistent pain following a traumatic injury.

Outlook on the Therapeutic Respiratory Devices Global Market to 2030

The "Therapeutic Respiratory Devices Market Size, Share & Trends Analysis Report by Product Type (Nebulizer, Humidifiers, Oxygen concentrators), by Technology, by Filters, by Region,...

European Infectious Disease Diagnostics Industry Market to 2031

The "European Infectious Disease Diagnostics Industry Market - Country-Wise Analysis: Focus on Product, Testing Location, Infectious Disease Type, Infection Type, Technology, and End User...

Global Robot-assisted Surgical Devices: Increase in Demand for Patient-specific Surgeries Driving the Market

The "Global Robot-assisted Surgical Devices (RASD) Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering. An aging population and accompanying retirements will cause a...

Blood Transfusion and Intravenous Equipment Market Global Report 2022-2026

"Global Blood Transfusion and Intravenous Equipment Market" report has been added to ResearchAndMarkets.com's offering. The scope of this report is broad. It covers blood transfusion...

Implantable Defibrillators Global Market to 2030

Implantable Defibrillators Market by Product Type : Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The global implantable defibrillators...

Global Robot-assisted Surgical Devices Growth Opportunities 2022: AI for Robotic Surgery to Predict Surgical Outcomes and Minimize Variability

Robot-assisted Surgical Devices The "Global Robot-assisted Surgical Devices (RASD) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report estimates the aging population and accompanying...

Global Coronavirus Testing Kits Market Report 2022-2027

"Global Coronavirus Testing Kits Market, By Type of Test (Molecular v/s Serological), By Use (Multiple Test vs Single Test), By Full Test Time, By...

Global $5.83 Bn Medical Lasers Systems Markets to 2028

"Medical Lasers Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Diode Lasers, Solid-State Lasers , and Dye Lasers),...
spot_imgspot_img

Recent News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”